 intraperiton lymphokine-activ killer-cel therapi malign periton caviti autolog lymphokine-activ killer lak cell recombin human IP patient malign periton space patient ovarian cancer colorect cancer patient endometri carcinoma primari small-bowel adenocarcinoma ovarian cancer patient twelv colorect cancer patient patient endometri carcinoma therapi patient u/kg hour IV day day underw daili leukapheresi day lak cell vitro peripher blood mononuclear cell day IP day tenckhoff cathet davol inc cranston RI u/kg IP hour patient cycl therapi toxic side effect minor hypotens fever chill rash nausea abdomin pain distens diarrhea oliguria fluid retent thrombocytopenia minor elev liver function test discontinu patient grand mal seizur colon perfor felt treatment-rel IP fibrosi patient limit cyclic administr therapi patient ovarian cancer patient colorect cancer patient laparoscopy- laparotomy-docu partial respons lak cell IP cancer patient moder short-term toxic modest therapeut efficaci further investig form adopt immunotherapi problem IP fibrosi IP dose justifi initi result